A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...

The research uncovers key genetic mutations that affect cancer treatment responses and develops a predictive tool for ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy have developed ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

including lung cancer. The combination craze In fact, the immunotherapy field has seen some of the most frenzied licensing and partnering of any therapy area in 2014. The message this year has ...

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...

A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...

Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma Interest Providence, RI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA) today announced newly ...

Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

Ocean Biomedical (OCEA) announced newly published research findings demonstrating the ability of its proprietary cancer immunotherapy ...

A new analysis shows that, among patients with metastatic non-squamous non-small cell lung cancer, the benefits of immunotherapy hold true regardless of the presence of a KRAS mutation. A major new ...